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PSYCHIATRIC COMPLICATIONS OF CHLOROQUINE 
M.S. BHATIA, S.C. MALIK 
Sixty patients with chloroquine induced psychiatric complications are reported in the present series. 
Psychosis was the most common complication followed by anxiety state and seizures. The maximum 
number of patients were between the ages of 6 and 10 years and females (70.0%) outnumbered the 
males (30.0%). Headache and sleeplessness were found to be more common amongpatients developing 
psychiatric complications of chloroquine. The symptoms disappeared within 2 to 21 days after the 
discontinuation of chloroquine. 
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INTRODUCTION  RESULTS 
The expanding awareness of medication induced 
behavioral changes among non-psychiatric patients 
and an increasing number of drug related hospital 
admissions has increased the role of a psychiatrist in 
a general hospital (Shader, 1972). It is now widely 
known that certain drugs, such as isoniazid, steroids, 
reserpine, clonidine, levodopa, etc. cause 
psychiatric symptoms, but the behavioral toxicity 
and lethality of chloroquine have received little at-
tention in the medical and psychiatric literature 
(Good & Shader, 1977). A large number of reports 
are now available which mention chloroquine in-
duced psychiatric side effects (Reagan, 1985; Bhatia 
et al, 1988; Bhatia, 1991), suicide (Good & Shader, 
1977) and lethality due to overdose (Wilkey, 1973; 
Good & Shader, 1977). The present study was 
designed to explore the pattern of psychiatric com-
plications induced by chloroquine. 
MATERIAL AND METHODS 
The present study analyses sixty patients with 
chloroquine induced psychiatric complications, 
seen in a general hospital psychiatry OPD (of Smt. 
Sucheta Kriplani and Guru Teg Bahadur Hospitals, 
Delhi) over a period from January 1987 to December 
1992. All were first seen by the pediatrician or 
medical specialist, who evaluated and investigated 
the cases thoroughly before referring the patients to 
a psychiatrist. Patients with a past history of mental 
illness, mental retardation or epilepsy were excluded 
from the study. The cases were classified according 
to ICD-9 (WHO, 1978). A control group consisting 
of thirty age and sex matched patients who took 
chloroquine within the therapeutic range for an-
timalarial purposes, but without psychiatric com-
plications, were chosen from medical and pediatric 
wards to compare the side effect profile of chloro-
quine. These patients were also subjected to similar 
inclusion criteria. 
Of a total of sixty patients with chloroquine in-
duced psychiatric complications, the maximum 
belonged to the 6-10 age group (23.3%) follow^ by 
the 11-15 age group (20.0%). There were a mini-
mum of patients below the age of 5 or above the age 
of 35. Females (70.0%) outnumbered males (30.0%) 
significantly (p<0.001). Patients who took chloro-
quine with milk were significantly (p<0.001) more 
in the study group as compared to the control group; 
there was no difference in the dose, salt of the drug 
(phosphate or sulphate) and mode of intake of drug 
(whether empty stomach or after meals) between the 
study and control groups. 
When the side effects of chloroquine as reported 
by patients in the study and control groups were 
compared, headache and sleeplessness were 
reported significantly more by patients belonging to 
the study group. The distribution of patients accord-
ing to psychiatric complications, age, sex, dosage 
and duration of onset is shown in Table 1. 
Tabid 
Psychiatric complications 
Complication 
1. Organic psychosis 
(n»32) 
2. Schizophrenia l§» 
M2) 
3. Mania like (n=4) 
4. Depression Ike 
(n=4) 
5. Anxiety state 
6. Seizures(n=4) 
Age Male 
(yre) 
6 to 36 
13 to 35 
10 to 16 
18 to 30 
28 to 32 
12 to 26 
12 
4 
-
-
• 
2 
Female Dosage 
(g) 
20 
8 
4 
4 
4 
2 
1.0 to 24 
(Mean 1.8) 
1.25 to 2.0 
(Mew 1.6) 
1.5 4,22 
1.5 42.4 
2.0 
1.0 420 
Onset 
(days) 
2 to4 
3 to 6 
5to7 
4 to7 
2to3 
3 to4 
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DISCUSSION 
Though the exact psychosocial details and 
prevalence of psychiatric complications of chloro-
quine are not yet known, 43.3% patients in the 
present series were found to be children. In the 
present study, more patients were found to be 
females. This is similar to other reports (Bhatia et al, 
1988) but the exact cause of this is not known. 
When the mode of the intake of chloroquine was 
compared, the patients who took chloroquine with 
milk were found to be more in the study group as 
compared to the control group. This could be due to 
the fact that milk might cause rapid absorption of 
chloroquine resulting in toxicity in some 
predisposed individuals. This hypothesis needs 
more elaboration by doing the serum levels of the 
drug in further studies. Among the side effects 
reported by the patients, headache and sleeplessness 
were found to be significantly more in the study 
group. The other side effects as reported by Rollo 
(1980) like nausea, vomiting, diarrhoea, anorexia, 
urticaria cc. were not found to be significantly dif-
ferent between the study and the control groups. 
Psychosis was found in 86.7% of patients. 
Though Burrel et al (1958) reported the first case of 
chloroquine induced psychosis, many more cases 
have been added since then (Good & Shader, 1977; 
Reagan, 1985; Bhatia et al, 1988; Garg et al, 1990; 
Bhatia, 1991). The psychosis that appeared in these 
cases after an intake ranging from 2.4 to 6.0 gm of 
chloroquine had occurred over a period between 4 
and 40 days; however, the cases in our series 
developed psychosis after receiving a total dose of 
1.0 to 2.4 gm, and within 2 to 7 days. The period of 
onset was minimum for organic psychosis followed 
by schizophrenia-like, depression-like and mania-
like psychosis. 
The common behavioral changes noted in 
patients were agitation, confusion, disorientation, 
irrelevant and incoherent talk, hallucinations (visual 
and auditory), delusions (control, reference, gran-
diose and somatic) and suicidal and homicidal idea-
tion. Other studies also report similar findings (Nasr, 
1981; Reagan, 1985); the reported duration of be-
havioral changes ranged from two days to eight 
weeks (Reagan, 1985), but in our series all fifty two 
cases im proved within three weeks after cessation of 
chloroquine. 
Many cases of attempted suicide have been 
reported both in children and adults (Good & 
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Shader, 1977), but in our series, suicidal and 
homicidal ideation were communicated by six cases 
(three cases each); there was, however, no suicidal 
or homicidal attempt. 
Although symptoms resembling acute anxiety 
attacks such as dryness of mouth, sweating, palpita-
tions, tremors, sinking sensation, sleeplessness, dif-
ficulty in concentration etc., have also been reported 
following chloroquine therapy (Good & Shader, 
1977), we have seen only four patients (28 to 32 
years old) who presented with these symptoms 
within 48 to 72 hours after taking 2 gm of chloro-
quine sulphate. 
Cases of chloroquine induced seizures have been 
reported after taking therapeutic and toxic doses 
(Kiel, 1964) of chloroquine; we observed four 
patients with seizures (grandmal type) following 
intake of therapeutic doses of chloroquine. An im-
portant observation is that these patients had herald-
ing signs of toxicity (like vomiting, diarrhoea, 
abdominal cramps etc.) prior to the seizure. The 
exact mechanism of seizures remains unknown but 
the evidence seems to point towards an idiosyncratic 
reaction in sensitive individuals. 
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